Ramachandra Sumant 4

4 · Lyell Immunopharma, Inc. · Filed Jun 12, 2026

AI-generated summary of this filing

Updated Jun 12, 2026

Lyell (LYEL) Director Ramachandra Sumant Receives Award

What Happened

Ramachandra Sumant, a director of Lyell Immunopharma (LYEL), received a derivative award of 9,250 shares on 2026-06-10. The grant is reported at a $0.00 price (total reported value $0), and the filing classifies the transaction as an award/acquisition (derivative), not an open-market purchase or sale.

Key Details

Transaction date: 2026-06-10; Form 4 filed 2026-06-12 (timely within the 2-business-day window).
Shares reported acquired: 9,250 derivative shares; reported acquisition price: $0.00.
Shares owned after transaction: Not disclosed in this Form 4.
Footnotes of note:
- F1: All share amounts reflect a 1-for-20 reverse split effective May 30, 2025.
- F2: Shares are held by the Sumant Ramachandra Rev Trust DTD 01/24/12; Reporting Person is grantor and trustee.
- F3: Vesting: the award vests on the earlier of (a) the date of the next annual meeting of stockholders following June 10, 2026 (or immediately prior if service ends due to not being re-elected) or (b) the first anniversary of June 10, 2026, subject to continued service.

Context

The filing describes a derivative award (commonly stock options or restricted stock units) but does not specify the instrument type or an immediate cash value; $0 reported grant price does not mean the economic value is zero.
Awards to directors are routine compensation; they are different from open-market purchases (which can be read as a direct bullish signal) and from sales (which may be for liquidity/tax reasons).

Form 4

Period: 2026-06-10

Director

Transactions

Award
Option (right to buy)
[F3]
2026-06-10+9,250→ 9,250 total
Exercise: $13.22Exp: 2036-06-09→ Common Stock (9,250 underlying)

Holdings

Footnotes (3)

[F1]On May 30, 2025, the Issuer effected a 1-for-20 reverse stock split of its common stock. All share and amounts reported herein reflect the reverse stock split.
[F2]Shares held by the Sumant Ramachandra Rev Trust DTD 01/24/12. The Reporting Person is grantor and trustee of the Sumant Ramachandra Rev Trust DTD 01/24/12.
[F3]The option shares shall vest on the earlier of (a) the date of the next annual meeting of the stockholders that occurs following June 10, 2026 (or the date immediately prior to such date if the Reporting Person's service as a director ends at such annual meeting due to the Reporting Person's failure to be reelected or the Reporting Person not standing for re-election); or (b) the first anniversary of June 10, 2026, subject to the Reporting Person providing continuous service through such date.

Signature

/s/ Mark Meltz, Attorney-in-Fact|2026-06-11

1 file